Serina Therapeutics Insider Sells $23K in Stock

Got story updates? Submit your updates here. ›

Randall Moreadith, an insider at Serina Therapeutics, Inc. (NYSEAMERICAN:SER), sold 6,500 shares of the company's stock on January 28th for a total value of $23,205. This is the latest in a series of insider sales by Moreadith, who has sold a total of 11,000 shares so far this year.

Why it matters

Insider trading activity can provide insights into a company's prospects and management's confidence in the business. While isolated insider sales are not necessarily a cause for concern, a pattern of selling by company insiders may signal potential issues or a lack of faith in the company's future performance.

The details

Moreadith, who holds the title of insider at Serina Therapeutics, sold the 6,500 shares at an average price of $3.57 per share. This follows two previous sales of 2,500 shares on January 22nd and 2,000 shares on January 21st, both at slightly lower prices. Serina Therapeutics is a biotechnology company focused on developing drugs to treat neurological diseases and pain.

• On January 28th, 2026, Randall Moreadith sold 6,500 shares of Serina Therapeutics stock.
• On January 22nd, 2026, Randall Moreadith sold 2,500 shares of Serina Therapeutics stock.
• On January 21st, 2026, Randall Moreadith sold 2,000 shares of Serina Therapeutics stock.